Non-clinical Evaluation of NT-175, an Autologous T Cell Product Engineered to Express an HLA-A*02:01-restricted TCR Targeting TP53 R175H and Resistant to TGF-b Inhibition.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要